Summary
Daewon Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells medicine and medical supplies in South Korea. It offers various medicines for circulatory, respiratory, antibiotic, chemotherapy, and psychoneurosis uses. The company's principal products include Oramin-F Soft Cap, a multivitamin product; Pelubi Tablet, a NSAID product for pain relief; Freefol-MCT Inj., a microemulsion propofol for the anti-exogenous infectious bacteria; Megex-I Susp, a medicine that supplements subalimentation of cancer patients; Trigel Susp, a therapy for gastritis and duodenal ulcer; and Renamezin Cap, a spherical carbonaceous adsorbent for chronic kidney disease. It also exports its products to approximately 45 countries primarily in Asia, Central and South America, the Middle East, etc. The company was founded in 1958 and is headquartered in Seoul, South Korea.
History
Daewon Pharmaceutical Co., Ltd. was founded in 1956 as a leading South Korean pharmaceutical company. Since then, the company has become a prominent provider of medical products to the Korean market. We have developed a strong presence in the domestic market as well as growing our presence internationally.
Mission
Our mission is to create innovative, safe, and effective products that improve people's lives. We strive to achieve the maximum therapeutic value in providing health products and medical care, while continuing to meet the needs of our customers.
Vision
Our vision is to build a world-class, successful and sustainable Korean pharmaceutical company, delivering the best in healthcare. We continue to provide innovative and high quality products to our customers, making Daewon Pharmaceutical Co., Ltd. a successful and reliable presence in the healthcare industry worldwide.
Key Team
Bon-Am Gu (Sr. Managing Director)
Recognition and Awards
Throughout our over 60 years of operations, Daewon Pharmaceutical Co., Ltd. has been continuously recognized for our dedication to quality and innovation. Over the years we have won numerous awards, including the Rational Drug Use Award from the Ministry of Health and Welfare, the Best Service Provider Award from the Korean Medical Association and the President's Award for Best Export Service from the Pharmaceutical Association of Korea.
References
